CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

2.560 -0.020 (-0.78%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CytomX Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why Is Acadia Pharmaceuticals (ACAD) Stock Down 18% Today? ↗

March 12, 2024

Acadia Pharmaceuticals stock is falling on Tuesday as investors in ACAD react to its failed Phase 3 clinical trial of pimavanserin.

Via InvestorPlace

Why Is CytomX Therapeutics (CTMX) Stock Down 18% Today? ↗

March 12, 2024

CytomX Therapeutics stock is falling hard on Friday as CTMX shareholders appear unimpressed by its latest earnings report.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 12, 2024

Via Benzinga

Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

March 12, 2024

Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fis

Via Benzinga

Recap: CytomX Therapeutics Q4 Earnings ↗

March 11, 2024

Via Benzinga

CytomX Therapeutics's Earnings Outlook ↗

March 08, 2024

Via Benzinga

Earnings Outlook For CytomX Therapeutics ↗

November 06, 2023

Via Benzinga

Earnings Preview For CytomX Therapeutics ↗

August 07, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 12, 2024

Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 11, 2024

Via Benzinga

Earnings Scheduled For March 11, 2024 ↗

March 11, 2024

Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.

Via Benzinga

Why Is CytomX Therapeutics Stock Shooting Higher Today ↗

June 30, 2023

CytomX Therapeutics, Inc (NASDAQ: CTMX) inked a pact with BVF Partners L.P.

Via Benzinga

CytomX Therapeutics Earnings Perspective: Return On Capital Employed ↗

March 28, 2023

Via Benzinga

CytomX Therapeutics Earnings Preview ↗

March 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 27, 2024

Via Benzinga

Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 30, 2023

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 30, 2023

Via Benzinga

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 28, 2023

Gainers

Via Benzinga

AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners ↗

March 28, 2023

Via Benzinga

Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket ↗

March 28, 2023

Gainers Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 28, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!

Via InvestorPlace

Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 27, 2023

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.

Via Benzinga

Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket ↗

March 27, 2023

Gainers Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) shares rose 38.5% to $2.05 in pre-market trading after gaining 8% on Friday.

Via Benzinga

Earnings Scheduled For March 27, 2023 ↗

March 27, 2023

Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for its...

Via Benzinga

Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer

March 24, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs...

Via FinancialNewsMedia

5 Most Expensive Health Care Stocks You Should Worry About ↗

January 12, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

CytomX Therapeutics (CTMX) Stock Jumps 50% on Moderna Deal ↗

January 06, 2023

CytomX Therapeutics announced a licensing deal with Moderna, which may supercharge the underlying ambitions of CTMX stock.

Via InvestorPlace

Dow Jumps 700 Points; S&P 500 Rises Over 2% ↗

January 06, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 06, 2023

Via Benzinga

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.